Immunhistochemical analysis of HER-2 in tumors showing an increased number of HER-2 genes but a HER-2:CEP-17 ratio of less than 2

被引:0
|
作者
Kyshtoobayeva, AJ [1 ]
Bloom, KJ [1 ]
机构
[1] ChromaVis Med Syst, Irvine, CA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
167
引用
收藏
页码:39A / 39A
页数:1
相关论文
共 50 条
  • [21] Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers
    Haas, Susanne
    Gevensleben, Heidrun
    Rabstein, Sylvia
    Harth, Volker
    Pesch, Beate
    Bruening, Thomas
    Justenhoven, Christina
    Brauch, Hiltrud
    Hamann, Ute
    Ko, Yon-Dschun
    Baisch, Christian
    Fischer, Hans-Peter
    Buettner, Reinhard
    ONCOLOGY REPORTS, 2009, 21 (02) : 299 - 304
  • [22] Herceptin and the Her-2 receptor
    Brandt, B
    CLINICA CHIMICA ACTA, 2005, 355 : S21 - S21
  • [23] HER-2 intratumoral heterogeneity
    Arena, Vincenzo
    Pennacchia, Ilaria
    Vecchio, Fabio Maria
    Carbone, Arnaldo
    MODERN PATHOLOGY, 2013, 26 (04) : 607 - 609
  • [24] HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice
    Reilly, RT
    Gottlieb, MBC
    Ercolini, AM
    Machiels, JPH
    Kane, CE
    Okoye, FI
    Muller, WJ
    Dixon, KH
    Jaffee, EM
    CANCER RESEARCH, 2000, 60 (13) : 3569 - 3576
  • [25] A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system
    Marcela Mrhalova
    Roman Kodet
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 321 - 329
  • [26] Genetic Regulation of the Response to Her-2 DNA Vaccination in Human Her-2 Transgenic Mice
    Radkevich-Brown, Olga
    Jacob, Jennifer
    Kershaw, Nfichael
    Wei, Wei-Zen
    CANCER RESEARCH, 2009, 69 (01) : 212 - 218
  • [27] Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
    Lal, P
    Salazar, PA
    Ladanyi, M
    Chen, BY
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2003, 5 (03): : 155 - 159
  • [28] Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer
    Salvadori, B
    Pinzani, P
    Distante, V
    Casella, D
    Bianchi, S
    Paglierani, M
    Vezzosi, V
    Neumann, R
    Cataliotti, L
    Pazzagli, M
    Orlando, C
    CLINICAL CHEMISTRY, 2005, 51 (01) : 254 - 256
  • [29] Her-2 Immunohistochemical expression in oral squamous cell carcinomas is associated with polysomy of chromosome 17, Not Her-2 amplification
    Papavasileiou D.
    Tosios K.
    Christopoulos P.
    Goutas N.
    Vlachodimitropoulos D.
    Head and Neck Pathology, 2009, 3 (4) : 263 - 270
  • [30] A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system
    Mrhalova, Marcela
    Kodet, Roman
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (05) : 321 - 329